Publishers

Need unique free news content for your site customized to your audience?

Let's Discuss

By: citybiz
August 21, 2025

Curated TLDR

Mileutis Wins 2025 AgTech Breakthrough Award for Dairy Productivity Solution

Mileutis, a leading ag-biotech company developing antibiotic-free biologic therapies for the dairy industry, today announced that its lead product, IMILAC, has been named the winner of the 2025 AgTech Breakthrough Award for the category of Dairy Productivity Solution.

IMILAC is a milk-derived, residue-free therapy that strengthens cows’ natural immune systems to help prevent and treat mastitis without relying on antibiotics. Proven in large-scale clinical trials to improve milk yield, enhance milk quality and reduce waste from discarded milk, IMILAC offers dairy farmers a sustainable path to higher productivity and healthier herds, replacing commonly used antibiotic and hormone treatments.

“This recognition is a milestone for Mileutis and a testament to the power of science-driven innovation in agriculture,” said David Javier Iscovich, CEO of Mileutis. “With IMILAC, we’re not only helping farmers produce more and better-quality milk, we’re also tackling the urgent global challenge of antimicrobial resistance. This award underscores the potential for solutions that benefit animal health, human health and the planet.”

The AgTech Breakthrough Awards honor excellence and innovation across agricultural technology, recognizing companies and products that are transforming the industry through sustainable, impactful solutions.

“IMILAC has more than a decade of research into naturally occurring milk peptides and their ability to activate the cow’s immune defenses,” added Dr. Jose Iscovich, Chief Scientific Officer at Mileutis. “By replacing antibiotics with a natural, residue-free solution, we can protect animal health, slow the spread of resistant bacteria and drive sustainability within the dairy industry – all without compromising productivity.”

For more information about Mileutis, visit www.mileutis.com.

About Mileutis

Mileutis is a clinical-stage biopharmaceutical company developing natural, peptide-based therapies to transform animal health and food production. Its lead product, IMILAC, is a patented biologic designed to replace antibiotics used in treating mastitis – the most prevalent disease in dairy cows and hormones used in specific geographies around the world. With a focus on improving animal welfare, enhancing milk quality and promoting sustainable farming, Mileutis is advancing a healthier, more efficient future for the global dairy industry.

The post Mileutis Wins 2025 AgTech Breakthrough Award for Dairy Productivity Solution appeared first on citybiz.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This contant was orignally distributed by citybiz. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Mileutis Wins 2025 AgTech Breakthrough Award for Dairy Productivity Solution.

{site_meta && site_meta.display_name} Logo

citybiz

citybiz is a publisher of news and information about business, money, and people - including interviews, questions and answers with thought leaders. citybiz reaches business owners, C-level, senior managers and directors in 20 major U.S. city markets.